FDA warning letter - IPQ
FDA Warning Letter To Teva Highlights Need For Accurate Root Cause Investigations :: Pink Sheet
Teva receives warning letter over Actavis site
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva receives warning letter over Actavis site
Warning letter issued over manufacturing plant - European Pharmaceutical Manufacturer
FDA warning letter says Teva China plant has more work to do on API issues | Fierce Pharma
FDA Warning Letter Hits Akorn's Subpar Root Cause Investigations :: Pink Sheet
Teva plant tagged with warning letter for issues making schizophrenia drug | Fierce Pharma
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma
2017 Recap: FDA Warning Letter Observations and Trends | AssurX
FDA Urges Contamination Control in Warning Letters for Dominican, Indian Drug Manufacturing Faciliti | RAPS
Mid 2018 – Recap of Warning Letters, Import Alerts and Non-Compliances
Dear Dr. Woodcock, I am writing to bring to your attention a Warning Letter that Vanda received from the FDA on October 22, whic
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens
Teva faces drug price fixing charges, to cut 350 jobs in Israel; Wintac gets hit by FDA Warning Letter | Radio Compass Blog
FDA slaps Japanese drugmaker with warning letter for stymying inspection | Fierce Pharma
Mid-2017 Recap of FDA Warning Letters, Import Alerts & EU Non-Compliances | Radio Compass Blog
2016 — A year of data integrity issues and pharma non-compliances - Victimes d'Effets indésirables Graves ENDOXAN Cyclophosphamide Fatal adverse effects
FDA Outlines Warning Letters for Promotion of Prescription Pharmaceuticals – Policy & Medicine
FDA warning letter slams B. Braun management for persistent failures at U.S. plant | Fierce Pharma
